Aditxt (ADTX) had the highest return in Q3 2022 by a US stock, returning 2,237.9%.

ASSET	QUARTER	% RETURN
Aditxt (ADTX)	Q3 2022	2,237.93%
NewAmsterdam Pharma Company NV Warrant (NAMSW)	Q3 2022	841.25%
MMTEC (MTC)	Q3 2022	511.89%
Rhythm Pharmaceuticals (RYTM)	Q3 2022	500.49%
NeoVolta Inc Warrant (NEOVW)	Q3 2022	332.5%
Vigil Neuroscience (VIGL)	Q3 2022	262.55%
AMTD Digital (HKD)	Q3 2022	260%
Akero Therapeutics (AKRO)	Q3 2022	251.76%
Liberty Tripadvisor (LTRPB)	Q3 2022	205.85%
Astria Therapeutics (ATXS)	Q3 2022	202.34%
Heartbeam (BEAT)	Q3 2022	193.23%
Vertical Aerospace (EVTL)	Q3 2022	192.5%
NRx Pharmaceuticals (NRXPW)	Q3 2022	184.36%
Ventyx Biosciences (VTYX)	Q3 2022	182.9%
Sobr Safe (SOBR)	Q3 2022	182.08%
RDE (GIFT)	Q3 2022	173.33%
ZW Data Action Technologies (CNET)	Q3 2022	171.12%
Bioatla (BCAB)	Q3 2022	170.18%
Minerva Neurosciences (NERV)	Q3 2022	165.99%
Immuneering (IMRX)	Q3 2022	165.19%
Spero Therapeutics (SPRO)	Q3 2022	163.16%
Pliant Therapeutics (PLRX)	Q3 2022	161.45%
NLS Pharmaceutics (NLSPW)	Q3 2022	147.52%
Verona Pharma PLC ADR (VRNA)	Q3 2022	146.86%
Terns Pharmaceuticals (TERN)	Q3 2022	139.43%